# Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy

> **NCT05303337** · — · RECRUITING · sponsor: **Hôpital Européen Marseille** · enrollment: 120 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **OTHER:** Stool sampling
- **OTHER:** Blood plasma collection

## Key facts

- **NCT ID:** NCT05303337
- **Lead sponsor:** Hôpital Européen Marseille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-11
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303337, "Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05303337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*